Explicit Motor Imagery in Persistent Pelvic Pain

April 22, 2024 updated by: Borja Pérez-Domínguez, University of Valencia

Response in Patients With Persistent Pelvic Pain to Explicit Motor Imagery Through Auditory or Visual Input

The goal of this clinical trial is to compare the response of Explicit Motor Imagery interventions in patients suffering Persistent Pelvic Pain. The main question it aims to answer is:

• Does the modality of application of Explicit Motor Imagery, either through visual or auditory stimuli, influence the response in patients suffering Persistent Pelvic Pain?

Participants will receive an online Explicit Motor Imagery program either through visual inputs or auditory inputs. They will be instructed to follow the program en register their response.

Researchers will compare visual Explicit Motor Imagery and auditory Explicit Motor Imagery to see if different inputs generate different responses in patients suffering Persistent Pelvic Pain.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

49

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Valencia, Spain, 46010
        • University of Valencia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Experience persistent pain for a minimum duration of six months.
  • Achieve a minimum score of six points on the Chronic Pelvic Pain Questionnaire (CPPQ), a validated instrument designed to assess the discrimination of pain.

Exclusion Criteria:

  • Participants with a medically diagnosed condition that logically accounts for the presence of pain during the aforementioned six-month period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Visual Explicit Motor Imagery
6 exercises of Explicit Motor Imagery, administered on alternate days, using visual inputs in the form of images.
Other: Visual
Delivery of images to conduct several exercises of Explicit Motor Imagery
Experimental: Auditory Explicit Motor Imagery
6 exercises of Explicit Motor Imagery, administered on alternate days, using auditory inputs in the form of audio recordings.
Other: Auditory
Delivery of audio recordings to conduct several exercises of Explicit Motor Imagery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numerical Rating Scale
Time Frame: Baseline to two weeks
Self-administered scale that requires the patient to rate their pain intensity on a 0-10 scale, where 0 is no pain and 10 is the worst pain imaginable. Higher scores indicate worse outcomes.
Baseline to two weeks
Pain Vigilance and Awareness Questionnaire
Time Frame: Baseline to two weeks
Self-administered questionnaire to measure attention to pain. 16- item questionnaire, where each item is scored as a six- point Likert scale that ranges from zero (never) to five (always), resulting in a sum score between zero and 80. Higher scores indicate worse outcomes.
Baseline to two weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Movement Imagery Questionnaire-Revised
Time Frame: Baseline
Assesses visual and kinesthetic movement imagery abilities. Self-adminstered instrument comprised of 2 subscales: Visual Imagery (4 items) and Kinesthetic Imagery (4 items). Respondents assign a value from a 7-point scale, which indicates the ease or difficulty with which the movement was seen/felt. Higher scores indicate worse movement imagery abilities.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Valencia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2023

Primary Completion (Actual)

November 30, 2023

Study Completion (Actual)

November 30, 2023

Study Registration Dates

First Submitted

March 26, 2024

First Submitted That Met QC Criteria

April 1, 2024

First Posted (Actual)

April 2, 2024

Study Record Updates

Last Update Posted (Actual)

April 23, 2024

Last Update Submitted That Met QC Criteria

April 22, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CEUMA 187-2023-H

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pelvic Pain

Clinical Trials on Visual

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe